JESSICA LAUSE: Open Payments
NPI 1114591344 · MILAN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 11 payments from 8 companies in 2025. Trend: 2023 $323 · 2024 $164 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| ABBVIE INC. | 2 | $31 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Abbott Laboratories | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
| Amgen Inc. | 1 | $14 |
Products named: The Cologuard Plus Collection Kit, AIRSUPRA, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, QULIPTA, Rybelsus, UBRELVY, REPATHA.
Industry payments across OH — which companies pay providers there.
